Sort
35,931 grants matching “parkinsons”
Genetic characterization of atypical parkinsonism
$2,363,340Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
MOUSE BIRN
$2,363,204Arthur W Toga · University Of California Los Angeles · U24 · FY2008 · RR
Mouse BIRN
$2,363,204Arthur W Toga · University Of California Los Angeles · U24 · FY2008 · RR
Amyloid elimination by Hsp104 and substrate-optimized variants
$2,362,500James Shorter · University Of Pennsylvania · DP2 · FY2007 · OD
Immunologic and Imaging studies with TNF Therapy in Prodromal Synucleinopathies
$2,361,361Jesse Cedarbaum · Yale University · R01 · FY2025 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,359,595David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
$2,359,301Thomas N. Wichmann · Emory University · P50 · FY2022 · NS
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,355,912Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2023 · NS
Epidemiology of Dementia In An Urban Community
$2,355,854Richard Mayeux · Columbia University Health Sciences · P01 · FY2006 · AG
Discovering mechanisms that regulate organelle autophagy
$2,355,000Jacob Ellery Corn · University Of California Berkeley · DP2 · FY2017 · HL
Harnessing Mindset in 21st Century Healthcare
$2,355,000Alia Crum · Stanford University · DP2 · FY2016 · AT
Stem Cell Biology And Brain Disease
$2,350,200Ronald D McKay · Neurological Disorders And Stroke · Z01 · FY2007 · NS
MOUSE BIRN
$2,345,830Arthur W Toga · University Of California Los Angeles · U24 · FY2007 · RR
Mouse BIRN
$2,345,830Arthur W Toga · University Of California Los Angeles · U24 · FY2007 · RR
Brain-muscle microphysiological system enabled extracellular vesicle network for understanding aging in space
$2,344,810Mei He · University Of Florida · UG3 · FY2025 · TR
Effects-Related Biomarkers of Environmental Neurotoxic Exposures
$2,342,413Harvey Checkoway · University Of Washington · P42 · FY2010 · ES
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,341,200Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2020 · DA
Pharmaceutical Research Center
$2,340,738Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2012 · MD
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,340,234Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2025 · NS
Clinical Core
$2,340,055Joel Synes Perlmutter · University Of Pennsylvania · U19 · FY2024 · NS
Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease
$2,340,000Roger L Albin · University Of Michigan At Ann Arbor · P50 · FY2021 · NS
Longitudinal Imaging Biomarkers of Prodromal DLB
$2,339,366Kejal Kantarci · Mayo Clinic Rochester · U01 · FY2024 · NS
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
$2,339,326Thomas N. Wichmann · Emory University · P50 · FY2023 · NS
Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease
$2,339,061Roger L Albin · University Of Michigan At Ann Arbor · P50 · FY2022 · NS
Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy
$2,336,166Colum D Mackinnon · University Of Minnesota · RF1 · FY2022 · NS